The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development

Author： van der Burg S.H. de Jong A. Welters M.J.P. Offringa R. Melief C.J.M.

Publisher： Elsevier

ISSN： 0168-1702

Source： Virus Research, Vol.89, Iss.2, 2002-11, pp. : 275-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Phosphorylation of the HPV-16 E7 Oncoprotein during the Cell Cycle

By Massimi P. Banks L.

Virology, Vol. 276, Iss. 2, 2000-10 ,pp. : 388-394

Elsevier

Access to resources Recommend Favorite

NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16

By Pastrana D.V. Vass W.C. Lowy D.R. Schiller J.T.

Virology, Vol. 279, Iss. 1, 2001-01 ,pp. : 361-369

Elsevier

Access to resources Recommend Favorite

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

By Smahel M. Sma P. Ludvkova V. Vonka V.

Virology, Vol. 281, Iss. 2, 2001-03 ,pp. : 231-238

Elsevier

Access to resources Recommend Favorite

Establishment of the Human Papillomavirus Type 16 (HPV-16) Life Cycle in an Immortalized Human Foreskin Keratinocyte Cell Line

By Flores E.R. Allen-Hoffmann B.L. Lee D. Sattler C.A. Lambert P.F.

Virology, Vol. 262, Iss. 2, 1999-09 ,pp. : 344-354

Elsevier

Access to resources Recommend Favorite

Type Specific and Genotype Cross Reactive B Epitopes of the L1 Protein of HPV16 Defined by a Panel of Monoclonal Antibodies

By Kulski J.K. Sadleir J.W. Kelsall S.R. Cicchini M.S. Shellam G. Peng S.W. Qi Y.M. Galloway D.A. Zhou J. Frazer I.H.

Virology, Vol. 243, Iss. 2, 1998-04 ,pp. : 275-282

Elsevier

Access to resources Recommend Favorite